Thus, the marine steroids Certonardosterol D5 (30) and Certonardosterol Q3 (23) have excellent potential to become leads for the development of orally safe potent drugs for the treatment of various cancer types.
Thus, the marine steroids Certonardosterol D5 (30) and Certonardosterol Q3 (23) have excellent potential to become leadsfor the development of orally safe potent drugs for the treatment of various cancer types.